Elite in Transient Ischemic Attack (TIA)

Dar Dowlatshahi

Room C2182, 1053 Carling Avenue, K1Y 4E9, 
Ottawa, ON, CA 
Elite in Transient Ischemic Attack (TIA)
Room C2182, 1053 Carling Avenue, K1Y 4E9, 
Ottawa, ON, CA 
OverviewLocationsClinical Research

Overview

Dar Dowlatshahi practices in Ottawa, Canada. Mr. Dowlatshahi is rated as an Elite expert by MediFind in the treatment of Transient Ischemic Attack (TIA). His top areas of expertise are Stroke, Transient Ischemic Attack (TIA), Carotid Artery Disease, Thrombectomy, and Carotid Artery Surgery.

His clinical research consists of co-authoring 319 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 35 articles and participated in 1 clinical trial in the study of Transient Ischemic Attack (TIA).

Gender
Male

Locations

Room C2182, 1053 Carling Avenue, K1Y 4E9, Ottawa, ON, Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

EdoxabaN for IntraCranial Hemorrhage Survivors with Atrial Fibrillation (ENRICH-AF)
EdoxabaN for IntraCranial Hemorrhage Survivors with Atrial Fibrillation (ENRICH-AF)
Enrollment Status: Active_not_recruiting
Publish Date: January 16, 2025
Intervention Type: Drug, Other
Study Drug: Edoxaban
Study Phase: Phase 4
The Intracerebral Hemorrhage Acutely Decreasing Arterial Pressure Trial II
The Intracerebral Hemorrhage Acutely Decreasing Arterial Pressure Trial II
Enrollment Status: Terminated
Publish Date: November 06, 2024
Intervention Type: Drug
Study Drug: Labetalol+Hydralazine+Enalapril
Study Phase: Phase 2
Recovernow: A Multicentre Phase II Randomized Controlled Trial Of Early Mobile Tablet-Based Speech Therapy For Acute Stroke Patients With Aphasia
Recovernow: A Multicentre Phase II Randomized Controlled Trial Of Early Mobile Tablet-Based Speech Therapy For Acute Stroke Patients With Aphasia
Enrollment Status: Terminated
Publish Date: April 19, 2022
Intervention Type: Other
Study Phase: Not Applicable
Canadian Pradaxa Acute Stroke Safety Study
Canadian Pradaxa Acute Stroke Safety Study
Enrollment Status: Completed
Publish Date: June 19, 2020
Intervention Type: Drug
View 3 Less Clinical Trials

319 Total Publications

Brain Frailty and Functional Outcomes After Thrombolysis for Acute Ischemic Stroke.
Brain Frailty and Functional Outcomes After Thrombolysis for Acute Ischemic Stroke.
Journal: JAMA network open
Published: September 30, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Dowlatshahi's expertise for a condition
ConditionClose
View All 26 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile